Regulatory focus Small life sciences firms are their target, suggesting ongoing opportunities in regulatory strategy, submissions, and compliance for emerging therapeutics, biologics, and medical devices seeking FDA approvals.

Awards credibility Recent top regulatory services awards, plus a Life Sciences Review recognition, highlight proven FDA success. This can be leveraged to open conversations with potential clients seeking trusted regulatory partners.

Commercial leadership New executive hires in commercial services indicate a deliberate push into market-facing growth. Prospecting potential customers with coordinated regulatory and commercial strategy support could be compelling.

Partnerships plus growth Past collaborations with entities like Nucleus and ongoing product development capabilities position Facet as a turnkey partner for small companies needing end-to-end regulatory and development planning.

Tech-enabled services Existing tech stack and Gemstone platform history imply efficiency and collaboration advantages. Sales opportunities exist for clients seeking streamlined document management, regulatory publishing, and project coordination.